Truist Securities Maintains Buy on Inspire Medical Systems, Lowers Price Target to $363
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Richard Newitter maintains a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) but has lowered the price target from $380 to $363.
August 04, 2023 | 11:44 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inspire Medical Systems' price target has been lowered from $380 to $363 by Truist Securities, though the 'Buy' rating is maintained.
The lowering of the price target by Truist Securities may cause some short-term uncertainty among investors, potentially impacting the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the stock, which could balance out any negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100